NDR is pleased to announce research support for Ghada Maged for an ALS biomarkers project. Ms. Maged is currently completing an M. Sc. degree in Master of Neuroscience at Alexandria University in Egypt. She will complete a six-month internship at British Columbia University Visiting International Research Student (VIRS) program under the direction of Dr. Steve Pelech. The Student Award continues her research until January 31, 2023. We look forward to her results applying the NDR funded ALS phosphosite microarray developed by Dr. Pelech at Kinexus to animal and human samples.
top of page
Recent Posts
See AllDr. Susanne Petri, Hannover Medical School, Department of Neurology, in Hannover, Germany presented progress on her project “Therapeutic potential of drug interventions on microglia in ALS” to the N
130
NDR contributed to the work that was published by Dr. Adriano Chaves-Filho and the Dr. Sayuri Miyamoto team. To profile oxylipins in amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative dise
13
Neurodegenerative disease research is pleased to announce the progress of developing TVALA for the treatment of neuroinflammation in ALS. You can read about the trial and follow our progress .
29
bottom of page